Experimental Thrombosis Similar to Clinical Conditions Produced on the Hind-Legs of Minor Laboratory Animals

Angiology ◽  
1954 ◽  
Vol 5 (4) ◽  
pp. 307-311 ◽  
Author(s):  
R. Gottlob ◽  
R. May
1993 ◽  
Vol 27 (3) ◽  
pp. 206-221 ◽  
Author(s):  
Steinar Hunskaar ◽  
Richard T. Fosse

Allergy to laboratory animals is reviewed from a management point of view. Personnel issues, medical therapy, legal aspects, animal house environments and work routines are discussed. Modern methods of medical treatment are presented but it is recommended that environmental control should be given priority over drugs. Several ventilation and building design systems are reviewed from an ALA viewpoint. New technology (including down-ventilated benches, ventilated cages) is reviewed and possible effectiveness analysed. These systems, though potentially of value, lack adequate testing under clinical conditions. We conclude that there are many clinically untested techniques that remain to be proven and whose efficacy has not been documented.


1973 ◽  
Vol 82 (1) ◽  
pp. 23-35 ◽  
Author(s):  
David J. Lim

Although mammalian otoconia are known to be composed of calcium carbonate in calcite form, their morphogenesis, maintenance, and fate are not well understood. More information on these problem areas would aid considerably in better understanding various clinical conditions, such as cupulolithiasis and otolith degeneration. This study was intended to clarify the fine morphology of the otolith in normal and adverse conditions in laboratory animals with the use of the scanning and transmission electron microscopes. It was confirmed by this study that the mammalian otoconium is composed of an organic matrix and minerals (calcium carbonate). When the minerals are removed by decalcification, or chelation, a well arranged organic matrix, and even a nucleus, can be found in the crystal. The matrix of the crystal is identical to the gelatin matrix of the otolithic membrane. This finding supports the possibility that a normal protein matrix is a prerequisite for normal otoconia formation, and that the exchange of calcium ions can occur without altering the crystal structure. The vestibular dark cells, which are thought to be endolymph-secreting cells, appear to be capable of removing calcium from the otoconia that are attached to the dark cell surfaces. Although this evidence is only circumstantial, its consistency is impressive. On the basis of the foregoing, it is tempting to speculate that the dark cells participate in the removal of the dislodged otoliths, but further study is required to ascertain this point.


1989 ◽  
Vol 28 (04) ◽  
pp. 124-128 ◽  
Author(s):  
J. Spitz ◽  
N. Clemenz ◽  
K. Tittel ◽  
H. Weigand

In addition to its established oncological indications the sensitivity of bone scintigraphy is of steadily increasing significance in traumatology. Inactivity- induced osteoporosis plays a major role during the immobilization period in the plaster cast. In the region of the joints remodelling intensity may reach such a high level that the non-injured bone shows a higher rate of accumulation than the fracture. This process already begins between the third and fourth week of immobilization. The highest uptake is found after fracture of the scaphoid bone at the end of twelve weeks of immobilization. Control scintigraphies at intervals of several days are indicated to differentiate between various clinical conditions (pseudoarthrosis, activated osteoarthrosis, algodystrophy in case of doubtful x-ray results).


1997 ◽  
Vol 77 (05) ◽  
pp. 0955-0958 ◽  
Author(s):  
Carole A Foy ◽  
Peter J Grant

SummaryPAI-2 is a fibrinolytic inhibitor produced predominantly by monocytes. Most PAI-2 is intracellular making study in clinical conditions difficult. Abnormalities in production may be associated with inflammation and fibrinolysis at sites of tissue damage such as the atherosclerotic plaque.PAI-2 gene variants have been described: variant A consists of Asn120, Asn404 and Ser413 and variant B consists of Asp120, Lys404 and Cys413. We designed a PCR-RFLP assay using primers spanning the region containing Asn/Lys404 and Ser/Cys413. Variant B contains an Mwol restriction site. We analysed 302 Pima Indians and 286 healthy Caucasian volunteers. To investigate relationships between genotype and vascular disease we analysed 333 Caucasian patients undergoing coronary angiography.Gene variant B was more common in the Pimas than in Caucasians (p <0.0001). There was no significant difference in genotype distribution between the volunteers and patients. In the patients there was no association between genotype and either a history of MI or extent of coronary atheroma.


1985 ◽  
Vol 53 (03) ◽  
pp. 423-427 ◽  
Author(s):  
Stephen R Hanson ◽  
Laurence A Harker

SummarySuloctidil has been evaluated in the baboon for its antithrombotic efficacy using models of both acute and chronic arterial thrombogenesis. Acute thrombus formation was initiated by Dacron vascular grafts inserted as extension segments into chronic arteriovenous shunts. 111In-platelet deposition was measured by scintillation camera imaging for one hour. The results after oral administration of suloctidil (100 mg/kg/d in two divided doses) were not different from control studies. Moreover, concurrent heparin anticoagulation did not affect 111In-platelet deposition compared with control data. In contrast, ticlopidine (20 mg/ kg/d) significantly decreased platelet deposition that was reduced further by the addition of heparin.Chronic arterial-thromboembolism was initiated by segments of polyurethane (Biomer) cannula introduced into chronic arteriovenous shunts. Thrombus formation by the polyurethane cannula was measured as 111In-platelet turnover (corrected for removal of senescent platelets). Cannula platelet consumption was unaffected by suloctidil (20 mg/kg/d given in two divided doses for two days preceding and throughout the period of platelet survival measurement). In contrast, dipyridamole (10 mg/ kg/d) and sulfinpyrazone (100 mg/kg/d) completely interrupted cannula platelet consumption.We conclude that suloctidil probably has little or no effect on platelet-dependent thrombus formation.


2019 ◽  
Vol 331 (8) ◽  
pp. 25-27
Author(s):  
N.Y. Morozov ◽  
◽  
S.I. Tchukina ◽  
E.I. Koveshnikova ◽  
◽  
...  

Author(s):  
Rafael Antonio Caldart Bedin ◽  
Maisa Schultz ◽  
Antonio Bedin

Anesthesia for laboratory animals is a matter of biomedical concern and one of the most present dilemmas in the current bioethical debate. The use of anesthetic agents in experimental surgery aims at analgesia and restraining the animal, in order to achieve a reasonable degree of muscle relaxation and to produce sufficient analgesia. This practice requires the use of protocols for the administration of safe and efficient doses. Eight New Zealand rabbits were submitted to laparotomies demonstrating the surgical technique discipline of the local medical course. For pre-anesthetic medication, acepromazine 1 mg.kg-1 associated with ketamine 15 mg.kg-1 was used subcutaneously. Anesthesia was maintained with isoflurane and oxygen under a laryngeal mask in a Mapleson D anesthesia system and under spontaneous breathing. Hydration was performed with 10 ml.kg-1 saline every hour. A thermal mattress was used. Precordial stethoscope, pulse oximetry and clinical parameters were used for monitoring. For euthanasia, ketamine 10 mg.kg-1 associated with potassium chloride 19.1% 1 ml.kg-1 was used intravenously. The average weight of the rabbits was 2721.25 ± 275.01 grams and the duration of the anesthetic procedure was 120 ± 87 minutes. Discussion. In long-term anesthesia, such as laparotomies, the use of pre-anesthetic medication and then anesthetic induction by the combination of agents is recommended. However, anesthetic management requires monitoring to prevent insufficient or excessive doses from occurring.


Sign in / Sign up

Export Citation Format

Share Document